A New Scientist magazine study suggests it would not be difficult for a terrorist to obtain genes from the smallpox virus or a similarly vicious pathogen.
Researchers say a bioterrorist, armed with only a fake e-mail address, could probably order such deadly biological weapons online and receive them by mail within weeks.
Dozens of biotech firms now offer to synthesize complete genes from the chemical components of DNA, yet some conduct next to no checks on what they are being asked to make, or on who is making the request.
New Scientist said its investigation raises the frightening prospect of terrorists acquiring genes by mail-order for key bioweapon agents and then using them to engineer new and deadly pathogens.
New Scientist queried 16 biotech firms, asking each whether it screened orders for DNA sequences that might pose a bioterror threat. Of the 12 companies replying, only five said they screen every sequence received. Four said they screen some sequences, and three admitted not screening at all.
Whatever reasons deter some companies from screening orders, New Scientist said some firms freely admit they run no sequence screens.
"That's not our business," Bob Xue, a director of Genemed Synthesis in San Francisco, told the magazine.
Copyright 2005 by United Press International
Related stories:
Stem cells may enhance capability of heart cells to regenerate
During a fatal heart attack, at least 1 billion heart cells are killed in the left ventricle, one of the heart’s two big lower pumping chambers that move blood into the body.
Mapping brain cancer to find best treatment
There's never a good time to have brain cancer. Still, Karl DuBose tries to look on the bright side. "It's weird to say, but today - and here in Seattle - might be the best time and place to get this disease," said the 45-year-old Everett, Wash., man, who was slammed with the diagnosis last summer.
YouTube to host MGM films, TV shows
YouTube and Metro Goldwyn Mayer (MGM) announced on Monday that the popular video-sharing website will host some full-length television shows and films from the famed Hollywood studio.
Google offeres up a new vision of computing's future
Tuesday, and it has little to do with desktops or laptops. It's a future that focuses on mobility, with access to the Internet - and the ability to search its vastness, of course - no matter where you are from a device that clips to your belt or sits in your purse. The Google phone has arrived.
Supercomputers join cancer fight
Edmonton-A University of Alberta physicist will lead the fight against cancer, armed with a supercomputer and the will to make Alberta one of the world's top innovation centres.
3 sequencing companies join 1000 Genomes Project
Leaders of the 1000 Genomes Project announced today that three firms that have pioneered development of new sequencing technologies have joined the international effort to build the most detailed map to date of human genetic variation as a tool for medical research. The new participants are: 454 Life Sciences, a Roche company, Branford, Conn.; Applied Biosystems, an Applera Corp. business, Foster City, Calif.; and Illumina Inc., San Diego.
Gene therapy increases survival for end-stage head and neck cancer
A gene therapy invented at The University of Texas M. D. Anderson Cancer Center is the first to succeed in a U.S. phase III clinical trial for cancer, as announced today at the American Society of Gene Therapy annual meeting in Boston.
New findings challenge established views about human genome
A team of researchers led by University of Virginia Health System geneticists has uncovered a major secret in the mystery of how the DNA helix replicates itself time after time. It turns out that it is not just the sequence of the bases (building blocks) in the DNA, but also how loosely or tightly the chromatin (the material that makes up chromosomes) is packed at different points of the chromosome that is critical.